Dr. Cecelia H. Boardman, M.D.
Gynecologic Oncology (Gynecologic Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 218
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: Perelman School of Med at the University of Pennsylvania
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gynecologic Oncology Physician primary
VA license 0101227659 -
Obstetrics & Gynecology Physician
VA license 0101227659
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medical College of Virginia Hospitals Richmond, VA
- Cjw Medical Center Richmond, VA
- Henrico Doctors' Hospital Richmond, VA
- Spotsylvania Regional Medical Center Fredericksburg, VA
Medical groups
- Virginia Gynecologic Oncology LLC (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 218
- Services billed
- 804
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 199 | 62 |
| Insertion of needle into vein for collection of blood sample | 175 | 66 |
| Established patient office or other outpatient visit, 30-39 minutes | 154 | 90 |
| Established patient office or other outpatient visit, 20-29 minutes | 76 | 58 |
| Automated urinalysis test | 30 | 18 |
| Collection of blood sample from implanted device | 29 | 19 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 28 | 16 |
| New patient office or other outpatient visit, 45-59 minutes | 26 | 26 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 15 | 15 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 97 payments worth $73,014 in total to this clinician.
| GlaxoSmithKline, LLC. | $41,690 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $18,015 |
| AbbVie Inc. | $12,203 |
| Meditrina | $253 |
| Eisai Inc. | $219 |
| Merck Sharp & Dohme LLC | $142 |
| Pfizer Inc. | $91.03 |
| Novartis Pharmaceuticals Corporation | $59.70 |
| Compensation for services other than consulting (speaking, faculty) | $45,735 |
|---|---|
| Consulting Fee | $15,901 |
| Travel and Lodging | $8,427 |
| Food and Beverage | $2,951 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Dec 10, 2025 | Consulting Fee LYNPARZA · Oncology | $8,200 |
| GlaxoSmithKline, LLC. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $5,700 |
| GlaxoSmithKline, LLC. Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $5,700 |
| AbbVie Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $3,875 |
| AstraZeneca Pharmaceuticals LP Jan 3, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $3,280 |
| AstraZeneca Pharmaceuticals LP Sep 15, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $3,280 |
| GlaxoSmithKline, LLC. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Jul 11, 2025 | Consulting Fee JEMPERLI · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $3,200 |
All 32 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Dec 10, 2025 | Consulting Fee LYNPARZA · Oncology | $8,200 |
| GlaxoSmithKline, LLC. Dec 10, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Baltimore, MD · in-kind | $75.00 |
| GlaxoSmithKline, LLC. Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $5,700 |
| GlaxoSmithKline, LLC. Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $475 |
| GlaxoSmithKline, LLC. Oct 29, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Savannah, GA · in-kind | $1,340 |
| GlaxoSmithKline, LLC. Oct 29, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Savannah, GA · in-kind | $218 |
| GlaxoSmithKline, LLC. Oct 10, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $950 |
| AstraZeneca Pharmaceuticals LP Sep 15, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $3,280 |
| AbbVie Inc. Aug 23, 2025 | Travel and Lodging ELAHERE · ONCOLOGY · travel to ROSEMONT, IL · in-kind | $554 |
| AbbVie Inc. Aug 22, 2025 | Travel and Lodging ELAHERE · ONCOLOGY · travel to ROSEMONT, IL · in-kind | $204 |
| GlaxoSmithKline, LLC. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $5,700 |
| AbbVie Inc. Aug 11, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $2,325 |
| GlaxoSmithKline, LLC. Jul 23, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Greenville, NC · in-kind | $1,202 |
| GlaxoSmithKline, LLC. Jul 11, 2025 | Consulting Fee JEMPERLI · ONCOLOGY | $3,200 |
| AbbVie Inc. Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $1,550 |
| GlaxoSmithKline, LLC. Jun 16, 2025 | Consulting Fee JEMPERLI · ONCOLOGY | $1,631 |
| GlaxoSmithKline, LLC. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Apr 22, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Ambler, PA · in-kind | $1,206 |
| GlaxoSmithKline, LLC. Apr 22, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Ambler, PA · in-kind | $243 |
| AbbVie Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $3,875 |
| GlaxoSmithKline, LLC. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) JEMPERLI · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Apr 2, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Westminster, MD · in-kind | $1,129 |
| AstraZeneca Pharmaceuticals LP Apr 1, 2025 | Consulting Fee | $2,870 |
| GlaxoSmithKline, LLC. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $1,600 |
| GlaxoSmithKline, LLC. Mar 12, 2025 | Travel and Lodging JEMPERLI · ONCOLOGY · travel to Gaithersburg, MD · in-kind | $945 |
| AbbVie Inc. Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) ELAHERE · ONCOLOGY | $3,000 |
| GlaxoSmithKline, LLC. Feb 26, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Bel Air, MD · in-kind | $1,236 |
| GlaxoSmithKline, LLC. Feb 21, 2025 | Compensation for services other than consulting (speaking, faculty) ZEJULA · ONCOLOGY | $1,200 |
| GlaxoSmithKline, LLC. Jan 29, 2025 | Travel and Lodging ZEJULA · ONCOLOGY · travel to Catonsville, MD · in-kind | $75.00 |
| AstraZeneca Pharmaceuticals LP Jan 3, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $3,280 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.